METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers [CRISPR screen_H358]

ABSTRACT: In this study, we used a targeted CRISPR/CasRx-METTL3 screen to identify m6A peaks that are critical for prostate and lung cancer.

ORGANISM(S): Homo sapiens

PROVIDER: GSE312890 | GEO | 2025/12/15

REPOSITORIES: GEO